ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) is -13.24% lower on its value in year-to-date trading and has touched a low of $0.32 and a high of $2.43 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IPA stock was last observed hovering at around $0.37 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.36, the stock is -18.85% and -23.21% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 45.85 million and changing -3.95% at the moment leaves the stock -47.69% off its SMA200. IPA registered -81.20% loss for a year compared to 6-month loss of -55.90%.
The stock witnessed a -33.85% gain in the last 1 month and extending the period to 3 months gives it a 2.53%, and is -16.93% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 18.57% over the week and 12.26% over the month.
ImmunoPrecise Antibodies Ltd (IPA) has around 101 employees, a market worth around $16.35M and $17.69M in sales. Profit margin for the company is -114.53%. Distance from 52-week low is 9.98% and -85.30% from its 52-week high. The company has generated returns on investments over the last 12 months (-63.68%).
with sales reaching $6.58M over the same period.The EPS is expected to grow by 63.48% this year, but quarterly earnings will post 0.92% year-over-year. Quarterly sales are estimated to grow 5.85% in year-over-year returns.
The shares outstanding are 30.29M, and float is at 20.05M with Short Float at 1.79%.
The top institutional shareholder in the company is INGALLS & SNYDER LLC with over 1.3 million shares valued at $$1.31 million. The investor’s holdings represent 5.0209 of the IPA Shares outstanding. As of 2024-06-30, the second largest holder is RENAISSANCE TECHNOLOGIES LLC with 63910.0 shares valued at $$64549.0 to account for 0.2477 of the shares outstanding. The other top investors are BANK OF MONTREAL /CAN/ which holds 55857.0 shares representing 0.2165 and valued at over $$61443.0, while NORTHERN TRUST CORP holds 0.1966 of the shares totaling 50730.0 with a market value of $$51238.0.
